Skip to main content
PBM
NASDAQ Life Sciences

Psyence Biomedical to Vote on Proposed Share Consolidation at Upcoming Meeting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.822
Mkt Cap
$1.488M
52W Low
$0.662
52W High
$17.933
52W Position info
24% above low
Off High info
95% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PBM sits 24% above its 52-week low of $0.662 on light trading volume (0.2× avg).

Summary

Psyence Biomedical Ltd. will hold a shareholder meeting to vote on a proposed share consolidation, a significant corporate action often used to address low stock prices.


Key Events · Corporate Governance and Compliance · PBM

  • Shareholder Meeting Scheduled

    An Annual and Special Meeting of Shareholders is scheduled for January 22, 2026, to discuss several corporate matters.

  • Proposed Share Consolidation

    Shareholders will vote on a special resolution to approve a proposed consolidation of the company's common shares.

  • Director Elections and Auditor Appointment

    The meeting agenda also includes the election of directors and the appointment of MNP LLP as the company's auditor.


Analysis · PBM · Life Sciences

Psyence Biomedical Ltd. has filed an amendment to its 6-K, primarily to include details for an upcoming Annual and Special Meeting of Shareholders. A key proposal at this meeting is a special resolution to approve a share consolidation. While the amendment itself is administrative, the proposed share consolidation is a significant corporate action often undertaken by companies with low stock prices to increase their per-share value, potentially to meet exchange listing requirements or improve market perception. This move can be viewed negatively by investors as it often signals underlying challenges or a need to maintain compliance.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PBM was trading at $0.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $0.66 to $17.93. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PBM - Latest Insights

PBM
Oct 21, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.09
Real-time Price: $3.08 info
Change: -$1.01 (-25%) info
Market Cap: $11.729M info
PBM
Oct 15, 2026, 9:03 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.00
Real-time Price: $3.08 info
Change: -$0.925 (-23%) info
Market Cap: $11.729M info
PBM
Oct 05, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $3.08 info
Change: -$2.27 (-43%) info
Market Cap: $11.729M info
PBM
Sep 28, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.86
Real-time Price: $3.08 info
Change: -$2.78 (-47%) info
Market Cap: $11.729M info
PBM
Sep 23, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.42
Real-time Price: $3.08 info
Change: -$3.34 (-52%) info
Market Cap: $11.729M info